Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia

Published:2016-04 Issue:4 Volume:54 Page:380-385
ISSN:0025-7079
Container-title:Medical Care
language:en
Short-container-title:

Author:

Lin Pei-Jung,Winn Aaron N.,Parsons Susan K.,Neumann Peter J.,Weiss Elisa S.,Cohen Joshua T.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Public Health, Environmental and Occupational Health

Reference41 articles.

1. . The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia.;Lee;Blood,1998

2. . Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib.;Gambacorti-Passerini;J Natl Cancer Inst,2011

3. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.;Blood,2013

4. Five myths about cancer care in America.;Goldman;Health Affairs,2014

5. . American Society of Clinical Oncology guidance statement: the cost of cancer care.;Meropol;J Clin Oncol,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial and ethnic differences in disease course Medicare expenditures for beneficiaries with dementia;Journal of the American Geriatrics Society;2024-03-20

2. Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches;Clinical Drug Investigation;2024-01-05

3. Cost-effectiveness of childhood cancer treatment in Egypt: lessons to promote high-value care in a resource-limited setting based on real-world evidence;eClinicalMedicine;2023-01

4. Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells;Scientific Reports;2021-03-17

5. Cost effectiveness of therapeutic drug monitoring for imatinib administration in chronic myeloid leukemia;PLOS ONE;2019-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3